FDA Approves Nivolumab Plus Ipilimumab for the Treatment of Advanced HCC.
Year: 2020
Type: article
Source: PubMed
Author: Kevin Wright
Language: English
Subfield: Hepatology
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W3015471920
